Type 2 cytokines (e.g., IL-4 and IL-13) promote mucus hypersecretion, airway remodeling, and emphysema by enhancing mucin synthesis, airway mucosal permeability, fibrin deposition, and protease production (72–77). The gene discussed is IL13; the disease is pulmonary emphysema.